PCK Tri-Axis Balanced Series II-IV

Brassica nigra

Black Mustard

Tier IIPCK Tri-Axis Balanced Series

Target Trait

1.38×

fold-change

Sharp+Cooling+Kokumi balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-01259

Genomic Edits

GC Content

46.5%

Construct Length

4,755 bp

Promoter System

T7/SP6 cell-free

Expression System

In-vitro cell-free

Host Strain

Cell-free

Receptor Target

TRPA1 + TRPM8 + CaSR

IFI Score

138

Pathway Edits

TRPA1 pathway primary gene cluster for sharp (IFI-P) tri-axis component
TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
Tri-axis metabolic flux partitioning hub for concurrent PCK pathway operation
Cross-pathway regulatory circuit for balanced PCK triple-axis expression
Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPA1, TRPM8, and CaSR pathways simultaneously engineeredBalanced tri-axis expression strategy (PCK) with cross-pathway flux managementCell-free co-translation of multi-axis enzyme sets for in-vitro biochemical validation

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Tier II PCK triple-axis construct for advanced multi-modal sensory architecture combining sharp, cooling, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$699 · Tier II License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-M All Modalities